clinical study with the optimys hipstem and the RM pressfit cup

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010537

Enrollment

Registered

2016-06-15

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1

Interventions

Group 1: With this study are being researched the characteristics of the "optimys" hip stem and the RM pressfit cup. The study is expected to take 2 years. Target of the study is to capture and follo

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients with a primaryhip osteoarthritis , who receive a hip arthroplastic using the optimys hip stem and the RM pressfit cup. The patients have to be treatet in the "I.V. program" of the health insurance.

Exclusion criteria

Exclusion criteria: no "I.V.-Treatment" of the health insurance

Design outcomes

Primary

Measure	Time frame
Target of the study is to capture and follow up 50 patients in the orthopedic clinic "Marienstift" in Arnstadt to check the safety and effectiveness of a hip prosthesis. Follow up after 3, 6 and 18 month using the Harris HIP Score und the WOMAC.	—

Secondary

Measure	Time frame
Measurement sintering of the stem using Single image X-ray Analysis (EBRA)	—

Countries

Germany

Contacts

Public ContactNatividad Zeleny

Mathys Orthopädie GmbH

natividad.zeleny@mathysmedical.com+49 (0)1705722702

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026